Abstract
The purpose of this study is to assess patient, tumour and treatment related factors on quality of life (QoL) outcomes of patients who received definitive or postoperative radiotherapy ± chemotherapy for head and neck (H&N) cancer. In this cross-sectional study, 110 H&N cancer patients were evaluated in follow-up visit and were asked to fill out the European Organisation for Research and Treatment of Cancer QoL Core Questionnaire (QLQ-C-30) and H&N Module (QLQ-H&N35). Patients were also graded for their late side effects using EORTC/RTOG scoring system. The QLQ C-30 and QLQ-H&N35 mean scores were compared using ANOVA analysis for these variables: age, gender, occupation, educational status, social security status, place of residence, tumour localization, clinical stage, comorbidity, Karnofsky performance score, treatment modality and side effects. Median follow-up was 29 (4–155) months. Tumour localization was significant factor affecting physical (P = 0.03), social (P = 0.01), cognitive (P = 0.002) functioning. Treatment modality had significant impact on the physical (P = 0.02) and cognitive scores (P = 0.008). Global QoL was affected significantly by disease stage (P = 0.01) and occupation (P = 0.01). The QLQ-H&N35 scores were found significantly higher in patients with moderate/severe late morbidity. Tumour localization and the treatment modality are the most important factors affecting the QoL of H&N cancer patients treated definitively.
Similar content being viewed by others
References
International agency for Research on Cancer webpage, Cancer Mondial. Available via http://www-dep.iarc.fr
Hall SF, Groome PA, Rothwell D (2000) The impact of comorbidity on the survival of patients with squamous cell carcinoma of the head and neck. Head Neck 22(4):317–322. doi:10.1002/1097-0347(200007)22:4<317::AID-HED1>3.0.CO;2-0
Sturgis EM, Wei Q, Spitz MR (2004) Descriptive epidemiology and risk factors for head and neck cancer. Semin Oncol 31(6):726–733. doi:10.1053/j.seminoncol.2004.09.013
Lefebvre JL (2005) Current clinical outcomes demand new treatment options for SCCHN. Ann Oncol 16(Suppl 6):vi7–vi12. doi:10.1093/annonc/mdi452
Lawrence TS, Blackstock AW, McGinn C (2003) The mechanism of action of radiosensitization of conventional chemotherapeutic agents. Semin Radiat Oncol 13:13–21. doi:10.1053/srao.2003.50002
Gotay CC (1996) Trial-related quality of life: using quality of life assessment to distinguish among cancer therapies. J Natl Cancer Inst Monogr 20:1–6
Bjordal K, Ahlner-Elmqvist M, Tollesson E et al (1994) Development of a European Organization for Research and Treatment of Cancer (EORTC) questionnaire module to be used in quality of life assessments in head and neck cancer patients. EORTC Quality of Life Study Group. Acta Oncol 33(8):879–885. doi:10.3109/02841869409098450
Bjordal K, Hammerlid E, Ahlner-Elmqvist M et al (1999) Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35. J Clin Oncol 17(3):1008–1019
Hammerlid E, Bjordal K, Ahlner-Elmqvist M et al (2001) A prospective study of quality of life in head and neck cancer patients. Part I: at diagnosis. Laryngoscope 111(4 Pt 1):669–680. doi:10.1097/00005537-200104000-00021
Zackrisson B, Mercke C, Strander H et al (2003) A systematic overview of radiation therapy effects in head and neck cancer. Acta Oncol 42(5–6):443–461. doi:10.1080/02841860310014886
Bjordal K, de Graeff A, Fayers PM, et al (2000) A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group. Eur J Cancer 36(14):1796–1807
Hanna E, Sherman A, Cash D et al (2004) Quality of life for patients following total laryngectomy vs chemoradiation for laryngeal preservation. Arch Otolaryngol Head Neck Surg 130(7):875–879. doi:10.1001/archotol.130.7.875
Cengiz M, Ozyar E, Esassolak M et al (2005) Assessment of quality of life of nasopharyngeal carcinoma patients with EORTC QLQ-C30 and H&N-35 modules. Int J Radiat Oncol Biol Phys 63(5):1347–1353. doi:10.1016/j.ijrobp.2005.05.057
Huguenin PU, Taussky D, Moe K et al (1999) Quality of life in patients cured from a carcinoma of the head and neck by radiotherapy: the importance of the target volume. Int J Radiat Oncol Biol Phys 45(1):47–52. doi:10.1016/S0360-3016(99)00128-5
Tschudi D, Stoeckli S, Schmid S (2003) Quality of life after different treatment modalities for carcinoma of the oropharynx. Laryngoscope 113(11):1949–1954. doi:10.1097/00005537-200311000-00018
Singer S, Wollbrück D, Wulke C et al (2008) Validation of the EORTC QLQ-C30 and EORTC QLQ-H&N35 in patients with laryngeal cancer after surgery. Head Neck 28 Oct (available online)
Bansal M, Mohanti BK, Shah N et al (2004) Radiation related morbidities and their impact on quality of life in head and neck cancer patients receiving radical radiotherapy. Qual Life Res 13(2):481–488. doi:10.1023/B:QURE.0000018491.80646.bc
Jensen K, Bonde Jensen A, Grau C (2006) The relationship between observer-based toxicity scoring and patient assessed symptom severity after treatment for head and neck cancer. A correlative cross sectional study of the DAHANCA toxicity scoring system and The EORTC quality of life questionnaires. Radiother Oncol 78(3):298–305. doi:10.1016/j.radonc.2006.02.005
Machtay M, Moughan J, Trotti A et al (2008) Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol 26(21):3582–3589. doi:10.1200/JCO.2007.14.8841
Trotti A, Pajak TF, Gwede CK et al (2007) TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group. Lancet Oncol 8(7):613–624. doi:10.1016/S1470-2045(07)70144-4
Arraras Urdaniz JI, Arias de la Vega F, Manterola Burgaleta A et al (2005) Quality of life in patients with locally advanced head and neck cancer treated with chemoradiotherapy. Comparison of two protocols using the EORTC questionnaires (QLQ-C30, H and N35). Clin Transl Oncol 7(9):398–403. doi:10.1007/BF02716585
Sherman AC, Simonton S, Adams DC et al (2000) Assessing quality of life in patients with head and neck cancer: cross-validation of the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Head and Neck module (QLQ-H&N35). Arch Otolaryngol Head Neck Surg 126(4):459–467
Abendstein H, Nordgren M, Boysen M et al (2005) Quality of life and head and neck cancer: a 5-year prospective study. Laryngoscope 115(12):2183–2192. doi:10.1097/01.MLG.0000181507.69620.14
De Graeff A, De Leeuw JR, Ros WJ et al (2000) Pretreatment factors predicting quality of life after treatment for head and neck cancer. Head Neck 22(4):398–407. doi:10.1002/1097-0347(200007)22:4<;398::AID-HED14>;3.0.CO;2-V
Nordgren M, Jannert M, Boysen M et al (2006) Health-related quality of life in patients with pharyngeal carcinoma: a five-year follow-up. Head Neck 28(4):339–349. doi:10.1002/hed.20334
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Alicikus, Z.A., Akman, F., Ataman, O.U. et al. Importance of patient, tumour and treatment related factors on quality of life in head and neck cancer patients after definitive treatment. Eur Arch Otorhinolaryngol 266, 1461–1468 (2009). https://doi.org/10.1007/s00405-008-0889-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-008-0889-0